Success rate of methotrexate treatment for recurrent
Abortifacient Agents, Nonsteroidal
/ administration & dosage
Adult
Case-Control Studies
Chorionic Gonadotropin
/ blood
Drug Dosage Calculations
Drug Monitoring
/ methods
Female
Humans
Israel
/ epidemiology
Methotrexate
/ administration & dosage
Pregnancy
Pregnancy, Tubal
/ blood
Recurrence
Risk Factors
Treatment Outcome
Ectopic pregnancy
methotrexate
recurrent ectopic pregnancy
Journal
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
ISSN: 1364-6893
Titre abrégé: J Obstet Gynaecol
Pays: England
ID NLM: 8309140
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
26
7
2019
medline:
9
2
2021
entrez:
26
7
2019
Statut:
ppublish
Résumé
The aim of this study was to compare the success rate of methotrexate (MTX) treatment in patients with recurrent ectopic pregnancy (REP) and primary EP (PEP). A retrospective cohort study. The study cohort comprised all patients diagnosed with an EP and treated by intention with single-dose regimen of intramuscular MTX in a tertiary medical centre during 2010-2018. Cases (REP) and controls (PEP) were compared.262 patients had PEP and 32 had a REP. Women with REP had significantly higher gravidity order and higher incidence of previous abortions (5
Identifiants
pubmed: 31342806
doi: 10.1080/01443615.2019.1621819
doi:
Substances chimiques
Abortifacient Agents, Nonsteroidal
0
Chorionic Gonadotropin
0
Methotrexate
YL5FZ2Y5U1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM